You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

administration, cutaneous

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Needs and Preferences of Patients With Head-neck Cutaneous SCC

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +10 more
  • Regular care with additional administration of a semi-structured interview
  • Maastricht, Netherlands
    Maastricht University Medical Center+
Sep 13, 2023

Quality of Life in Cutaneous Lymphoma Patients Using Skindex29

Not yet recruiting
  • Cutaneous Lymphoma
  • Quality-of-Life Assessment
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
Aug 23, 2022

Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)

Not yet recruiting
  • Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Jun 5, 2023

GVHD, JNS Kinase, Topical Administration Trial run by the NIAMS (Ruxolitinib 1.5% cream, vehicle cream)

Terminated
Has Results
  • Graft Versus Host Disease
  • +2 more
  • Ruxolitinib 1.5% cream
  • vehicle cream
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 21, 2022

Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma

Recruiting
  • Clinical Stage 0 Cutaneous Melanoma AJCC v8
  • +21 more
  • Informational Intervention
  • Survey Administration
  • New Brunswick, New Jersey
  • +1 more
Apr 6, 2022

Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

Recruiting
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • +33 more
  • Informational Intervention
  • +4 more
  • Los Angeles, California
  • +4 more
Dec 14, 2022

Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,

Active, not recruiting
  • Folliculotropic Mycosis Fungoides
  • +7 more
  • Extracorporeal Photopheresis
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Decisional Conflicts, Health-related QoL and Satisfaction With

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +9 more
  • Regular care with additionally administration of questionnaires
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Jul 28, 2022

Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

Recruiting
  • Recurrent Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 18, 2022

Toxicity and Symptom Burden in Chronic Cancer Survivors With

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +7 more
  • Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 6, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Trial in

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir - Injectable Suspension (CAB LA), Rilpivirine -

Active, not recruiting
  • Human Immunodeficiency Virus Type 1 (HIV-1)
  • Cabotegravir - Injectable Suspension (CAB LA)
  • Rilpivirine - Injectable Suspension (RPV LA)
  • Macon, Georgia
  • +29 more
May 31, 2023

Microbiome on Immune Checkpoint Inhibitor Response in Melanoma

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Pathologic Stage IV Cutaneous Melanoma AJCC v8
  • Biospecimen Collection
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 31, 2022

Carcinoma, Basal Cell, Carcinoma, Cutaneous Squamous Cell Trial in Tübingen, Warsaw, Saint Gallen (L19IL2 +L19TNF)

Recruiting
  • Carcinoma, Basal Cell
  • Carcinoma, Cutaneous Squamous Cell
  • L19IL2 +L19TNF
  • Tübingen, Germany
  • +2 more
Apr 19, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma Trial in Rochester (Anti-PD-L1 Monoclonal Antibody

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +3 more
  • Anti-PD-L1 Monoclonal Antibody IMC-001
  • Punch Biopsy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Clinical Stage IIA Cutaneous Melanoma AJCC v8 Trial in Portland (drug, procedure, other)

Not yet recruiting
  • Clinical Stage IIA Cutaneous Melanoma AJCC v8
  • Portland, Oregon
    OHSU Knight Cancer Institute
Nov 27, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +3 more
  • Ipilimumab
  • Nivolumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 6, 2022

Localized Skin Lesion, Mycosis Fungoides Trial in Houston (Quality-of-Life Assessment, Questionnaire Administration, Radiation

Recruiting
  • Localized Skin Lesion
  • Mycosis Fungoides
  • Quality-of-Life Assessment
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 13, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +4 more
  • Dabrafenib Mesylate
  • +3 more
  • Philadelphia, Pennsylvania
    Perelman Center for Advanced Medicine
Dec 29, 2021

Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Stage I Cutaneous Squamous Cell Carcinoma of the Head and

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +17 more
  • Best Practice
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 19, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Houston

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Quality-of-Life Assessment
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022

Locally Advanced Melanoma, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8

Recruiting
  • Locally Advanced Melanoma
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 18, 2022

Quality of Life, Lifestyle, and Psychosocial Factors in Melanoma

Recruiting
  • Cutaneous Melanoma
  • Medical Chart Review
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Nov 19, 2021

Cutaneous Squamous Cell Carcinoma of the Head and Neck, Healthy Subject, Head Neck Cancer Trial in Houston (Biospecimen

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • +2 more
  • Biospecimen Collection
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 11, 2022

Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Gdansk (WP1220)

Completed
  • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
  • Gdansk, Poland
    Medical University of Gdansk
Jan 8, 2021